<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Mon, 16 Nov 2026 19:21:38 -0500--><rss version="2.0">
    <channel>
        <title>TuHURA Biosciences, Inc. (HURA) Press Releases</title>
        <link>https://ir.tuhurabio.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_0b4577ffa47b2b3b138998038d9a2607/tuhurabio/files/theme/images/logo-sm.png</url>
                <title>TuHURA Biosciences, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>

                            <item>
                <title><![CDATA[TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/55/tuhura-biosciences-reports-third-quarter-2026-financial-results-and-provides-a-corporate-update</link>
                <pubDate>Fri, 13 Nov 26 07:45:00 -0500</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/55/tuhura-biosciences-reports-third-quarter-2026-financial-results-and-provides-a-corporate-update</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Announces Three Presentations at the 68th American Society of Hematology Annual Meeting and Exposition]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/54/tuhura-biosciences-announces-three-presentations-at-the-68th-american-society-of-hematology-annual-meeting-and-exposition</link>
                <pubDate>Wed, 04 Nov 26 09:15:00 -0500</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/54/tuhura-biosciences-announces-three-presentations-at-the-68th-american-society-of-hematology-annual-meeting-and-exposition</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line Treatment of Patients with Deep Seated Metastatic Merkel Cell Carcinoma]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/53/tuhura-biosciences-provides-first-look-at-data-from-its-open-label-study-of-ifx-2-0-as-an-adjunctive-therapy-to-keytruda-in-first-line-treatment-of-patients-with-deep-seated-metastatic-merkel-cell-carcinoma</link>
                <pubDate>Mon, 26 Oct 26 07:30:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/53/tuhura-biosciences-provides-first-look-at-data-from-its-open-label-study-of-ifx-2-0-as-an-adjunctive-therapy-to-keytruda-in-first-line-treatment-of-patients-with-deep-seated-metastatic-merkel-cell-carcinoma</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/52/tuhura-biosciences-receives-new-u-s-patent-broadening-coverage-for-its-vista-inhibitor-tbs-2025</link>
                <pubDate>Tue, 13 Oct 26 07:45:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/52/tuhura-biosciences-receives-new-u-s-patent-broadening-coverage-for-its-vista-inhibitor-tbs-2025</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/51/tuhura-biosciences-receives-key-u-s-patent-for-its-groundbreaking-delta-opioid-receptor-dor-antibody-drug-conjugate-adc-technology</link>
                <pubDate>Mon, 05 Oct 26 07:45:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/51/tuhura-biosciences-receives-key-u-s-patent-for-its-groundbreaking-delta-opioid-receptor-dor-antibody-drug-conjugate-adc-technology</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood-Related Cancers]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/50/tuhura-biosciences-receives-fda-study-may-proceed-notice-and-ind-clearance-for-the-evaluation-of-its-tbs-2025-vista-inhibiting-antibody-in-molecularly-defined-subsets-of-aml-and-other-blood-related-cancers</link>
                <pubDate>Mon, 14 Sep 26 07:45:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/50/tuhura-biosciences-receives-fda-study-may-proceed-notice-and-ind-clearance-for-the-evaluation-of-its-tbs-2025-vista-inhibiting-antibody-in-molecularly-defined-subsets-of-aml-and-other-blood-related-cancers</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/49/tuhura-biosciences-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference</link>
                <pubDate>Tue, 08 Sep 26 07:45:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/49/tuhura-biosciences-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/48/tuhura-biosciences-reports-second-quarter-2026-financial-results-and-provides-a-corporate-update</link>
                <pubDate>Fri, 14 Aug 26 07:45:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/48/tuhura-biosciences-reports-second-quarter-2026-financial-results-and-provides-a-corporate-update</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/47/tuhura-biosciences-to-present-at-canaccord-genuitys-46th-annual-growth-conference</link>
                <pubDate>Wed, 22 Jul 26 07:40:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/47/tuhura-biosciences-to-present-at-canaccord-genuitys-46th-annual-growth-conference</guid>
                                                                                </item>
                    <item>
                <title><![CDATA[TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.tuhurabio.com/news-events/press-releases/detail/46/tuhura-biosciences-files-investigational-new-drug-application-for-evaluation-of-the-tbs-2025-vista-inhibiting-antibody-in-molecularly-defined-subsets-of-aml-and-other-blood-related-cancers</link>
                <pubDate>Mon, 15 Jun 26 07:45:00 -0400</pubDate>
                <guid>https://ir.tuhurabio.com/news-events/press-releases/detail/46/tuhura-biosciences-files-investigational-new-drug-application-for-evaluation-of-the-tbs-2025-vista-inhibiting-antibody-in-molecularly-defined-subsets-of-aml-and-other-blood-related-cancers</guid>
                                                                                </item>
            </channel>
</rss>